Company Data

ASLAN Pharmaceuticals Limited

Ticker
ASLN
Current Price
$0.6
Market Cap
$1.7M
Price Target
Refer to Report
52wk Range
$0.475 - $4
Advanced Market Data

Overview

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy